Efficacy and Safety of Astaxanthin in Volunteer With Refraction Errors
NCT ID: NCT05009810
Last Updated: 2021-08-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
180 participants
INTERVENTIONAL
2021-08-15
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of a Combination of Polyphenol-rich Extracts on the Protection of Retinal Cells Against Blue Light in the Prevention of Ocular Diseases
NCT06004570
Carotenoid Supplementation and Normal Ocular Health
NCT02147171
Effects of Lutein and Zeaxanthin Supplementation on Early Age-related Macular Degeneration
NCT01528605
Effects of Xanthophylls on Optical Density
NCT01316198
Effects of Lutein and Zeaxanthin Supplementation on Age-related Macular Degeneration
NCT01048476
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
astaxanthin 4 mg
The astaxanthin 4 mg will be taken 1 capsule once daily for 2 months.
astaxanthin 4 mg
They will take astaxanthin 4 mg 1 capsule once daily for 2 months.
astaxanthin 6 mg
The astaxanthin 6 mg will be taken 1 capsule once daily for 2 months.
astaxanthin 6 mg
They will take astaxanthin 6 mg 1 capsule once daily for 2 months.
Placebo
The placebo will be taken 1 capsule once daily for 2 months.
Placebo
They will take placebo 1 capsule once daily for 2 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
astaxanthin 4 mg
They will take astaxanthin 4 mg 1 capsule once daily for 2 months.
astaxanthin 6 mg
They will take astaxanthin 6 mg 1 capsule once daily for 2 months.
Placebo
They will take placebo 1 capsule once daily for 2 months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Refraction errors, dry eye, or blurred vision
* Have a willingness to participate in the study
Exclusion Criteria
* Have complications during the study
* Have astaxanthin more than 2 weeks
* Allergic to astaxanthin, seafood, or seaweed
* Osteoporosis or thyroid disease
* Immunodeficiency or taking immunosuppressants
* Liver and kidney diseases
* A person with a brain disorder, vision or hearing unusual
* Pregnancy or lactation
* Cannot follow the protocol
* During participated in other studies
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chulalongkorn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pornanong Aramwit, Pharm.D., Ph.D
Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EC2103320
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.